These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15662237)

  • 1. Serial echocardiographic assessment of left ventricular mass.
    Stolk RP; Bots ML
    J Hypertens; 2005 Feb; 23(2):460-1; author reply 461-2. PubMed ID: 15662237
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial echocardiographic assessment of left ventricular mass: how blinded should readers be?
    Gosse P; de Simone G; Dubourg O; Guéret P; Schmieder R
    J Hypertens; 2004 Sep; 22(9):1813-8. PubMed ID: 15311111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of long-term uncontrolled antihypertensive therapy on the echocardiographic signs of left-heart hypertrophy in patients with mild and moderate arterial hypertension].
    Lerman OV; Metelitsa VI; Filatova NP; Duda SG; Malysheva NV; Vygodin VA
    Ter Arkh; 1997; 69(1):43-6. PubMed ID: 9163049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension.
    Gosse P; Guez D; Guéret P; Dubourg O; Beauchet A; de Cordoüe A; Barrandon S
    J Hypertens; 1998 Apr; 16(4):531-5. PubMed ID: 9797199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.
    Schussheim AE; Diamond JA; Phillips RA
    Am J Cardiol; 2001 Jan; 87(1):61-5. PubMed ID: 11137835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Echocardiography of left ventricular mass in patients with essential hypertension].
    Christensen KL; Fenger-Grøn M; Buus NH
    Ugeskr Laeger; 2009 Nov; 171(45):3252-5. PubMed ID: 19887054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment.
    Muiesan ML; Salvetti M; Rizzoni D; Castellano M; Donato F; Agabiti-Rosei E
    J Hypertens; 1995 Oct; 13(10):1091-5. PubMed ID: 8586800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy and hypertension.
    Mancia G
    Eur Heart J; 1996 Jan; 17(1):7-8. PubMed ID: 8682133
    [No Abstract]   [Full Text] [Related]  

  • 9. Limited echocardiography for hypertensive left ventricular hypertrophy.
    Sheps SG; Frohlich ED
    Hypertension; 1997 Feb; 29(2):560-3. PubMed ID: 9040438
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA).
    Liljedahl S; Kahan T; Lind L; Arnlöv J
    Echocardiography; 2009 Aug; 26(7):753-8. PubMed ID: 19486119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies.
    de Simone G; Muiesan ML; Ganau A; Longhini C; Verdecchia P; Palmieri V; Agabiti-Rosei E; Mancia G
    J Hypertens; 1999 Dec; 17(12 Pt 2):1955-63. PubMed ID: 10703895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 13. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function.
    Gottdiener JS; Livengood SV; Meyer PS; Chase GA
    J Am Coll Cardiol; 1995 Feb; 25(2):424-30. PubMed ID: 7829797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between left ventricular mass and blood pressure in treated hypertension.
    Missault LH; De Buyzere ML; De Bacquer DD; Duprez DD; Clement DL
    J Hum Hypertens; 2002 Jan; 16(1):61-6. PubMed ID: 11840231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.
    Gottdiener JS; Reda DJ; Williams DW; Materson BJ; Cushman W; Anderson RJ
    Circulation; 1998 Jul; 98(2):140-8. PubMed ID: 9679720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes.
    Tse HF; Cheung BM; Ng W; Chan JK; Devereux RB; Lau CP
    J Card Fail; 2003 Apr; 9(2):122-7. PubMed ID: 12751133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.
    Derosa G; Mugellini A; Querci F; Franzetti I; Pesce RM; D'Angelo A; Maffioli P
    Sci Rep; 2015 Aug; 5():12603. PubMed ID: 26243165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of preclinical target organ damage in hypertension: left ventricular hypertrophy.
    Rosei EA;
    J Hypertens; 2002 Jan; 20(1):156-8. PubMed ID: 11791040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.